Robert Ang, President and CEO of Vor Bio, discusses innovative cancer therapies like shielded stem cell transplants and CAR T-cell therapies targeting AML and MDS. He emphasizes core values, hiring passionate individuals, and the evolving landscape of cancer treatment. The podcast unveils insights into the challenges and advancements in next-gen cancer therapies, company culture, and reflecting on career choices.

Robert Ang, CEO of Vor Bio, discusses using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia. Topics include personal background, challenges of personalized medicine in cancer treatment, potential applications of CRISPR technology, and financial challenges in biotechnology.